Tenva Capital

Tenva Capital

Home
Chat
Open Ideas
Closed Ideas
Case Studies
Archive
About

Open Ideas

Challenger Gold (CEL:ASX)
2.6x NTM EV/EBITDA. 75% of Today's Market Cap to be Generated in FCF Over Next 3 Years.
Nov 10 • 
Tenva Capital
Pioneer Credit: FY25 Update
Earnings Beat. Inflection on Track.
Aug 27 • 
Tenva Capital
Sanuwave Health: Q2 Update
Continued Execution.
Aug 11 • 
Tenva Capital
Select Harvests (SHV:ASX)
Structurally Broken Supply with Material Impending Cashflow Generation.
Aug 7 • 
Tenva Capital
Matrix Composites & Engineering (MCE:ASX)
~1.9x EV/EBITDA, Operating Leverage, Near-term Earnings Catalysts and Major LT Growth Optionality.
Jun 25 • 
Tenva Capital
Updates: Sanuwave and Pioneer
Underwriting the book to date
Jun 3 • 
Tenva Capital
Sanuwave Health (SNWV:NASDAQ)
Is this the Fastest-Growing, Profitable Medical Device Company in U.S. Wound Care?
May 9 • 
Tenva Capital
Diamond in the rough (PNC:ASX)
3x FY26 P/E, 0.3x conservative liquidation value with multiple near-term catalysts on the horizon.
Apr 15 • 
Tenva Capital
© 2025 Tenva Capital
Publisher Terms
Substack
Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture